Inflammatory cytokine levels in multiple system atrophy: A protocol for systematic review and meta-analysis

Medicine (Baltimore). 2020 Jul 31;99(31):e21509. doi: 10.1097/MD.0000000000021509.

Abstract

Background: Multiple system atrophy (MSA) is a fatal neurodegenerative disease that progresses very rapidly and has a poor prognosis. Some studies indicate that the level of inflammatory cytokines may be related to MSA. However, no consistent conclusion has been drawn yet. The purpose of our research is to perform a meta-analysis to investigate whether the level of inflammatory cytokines is altered in MSA.

Methods: Case-control studies on inflammatory cytokine levels in MSA will be searched in the following 3 databases: PubMed, Embase, and Web of Science from the database start time to March 17, 2020. Two independent authors will conduct research selection, data extraction, and quality evaluation. Data synthesis, subgroup analysis, sensitivity analysis, and the meta-analysis will be performed using Stata15.0 software.

Results: This study will provide a comprehensive review of all studies on inflammatory cytokine levels in MSA.

Conclusion: To the best of our knowledge, this study will be the first meta-analysis that provides the quantitative evidence of inflammatory cytokine levels in MSA.

Registration number: INPLASY202060034.

MeSH terms

  • Adult
  • Case-Control Studies
  • Cytokines / blood*
  • Female
  • Humans
  • Male
  • Meta-Analysis as Topic
  • Multiple System Atrophy / blood*
  • Multiple System Atrophy / mortality
  • Research Design
  • Systematic Reviews as Topic

Substances

  • Cytokines